Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07792928 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 1 Study to Evaluate the Safety and Effects of a Single Dose of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Adults.

Name: A Phase 1 Study to Evaluate the Safety and Effects of a Single Dose of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Adults. — clinical trial record (NCT07792928)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorShanghai Peptidstar Therapeutics Limited

Started2026-08-14

View on ClinicalTrials.gov ↗

The goal of this intervention study is to assess the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Participants. The main parameters it aims to answer are: Does a single dose of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in healthy participants impact the Safety, Tolerability, Pharmacokinetics, and Immunogenicity profiles? This study will be a - randomized, double blind, placebo-controlled study.

Trial Details

NCT Number	NCT07792928
Lead Sponsor	Shanghai Peptidstar Therapeutics Limited Collaborators: Emerald Clinical Trials Pty Ltd
Conditions	Psoriasis
Enrollment	40 participants
Start Date	2026-08-14
Primary Completion	2026-11-10 (estimated)
Study Completion	2026-11-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-28